Format

Send to

Choose Destination
Nat Rev Neurosci. 2013 Apr;14(4):248-64. doi: 10.1038/nrn3430. Epub 2013 Mar 6.

The changing scene of amyotrophic lateral sclerosis.

Author information

1
Laboratory of Neurobiology, VIB Vesalius Research Center, 3000 Leuven, Belgium. wim.robberecht@vib-kuleuven.be

Abstract

Several recent breakthroughs have provided notable insights into the pathogenesis of amyotrophic lateral sclerosis (ALS), with some even shifting our thinking about this neurodegenerative disease and raising the question as to whether this disorder is a proteinopathy, a ribonucleopathy or both. In addition, these breakthroughs have revealed mechanistic links between ALS and frontotemporal dementia, as well as between ALS and other neurodegenerative diseases, such as the cerebellar atrophies, myotonic dystrophy and inclusion body myositis. Here, we summarize the new findings in ALS research, discuss what they have taught us about this disease and examine issues that are still outstanding.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT01348451 NCT01640067.

PMID:
23463272
DOI:
10.1038/nrn3430
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center